Search details
1.
Genetically Encoded Cholesterol-Modified Polypeptides.
J Am Chem Soc
; 141(2): 945-951, 2019 01 16.
Article
in English
| MEDLINE | ID: mdl-30608674
2.
Recombinant Synthesis of Hybrid Lipid-Peptide Polymer Fusions that Self-Assemble and Encapsulate Hydrophobic Drugs.
Angew Chem Int Ed Engl
; 56(45): 13979-13984, 2017 11 06.
Article
in English
| MEDLINE | ID: mdl-28879687
3.
Injectable protease-operated depots of glucagon-like peptide-1 provide extended and tunable glucose control.
Proc Natl Acad Sci U S A
; 110(8): 2792-7, 2013 Feb 19.
Article
in English
| MEDLINE | ID: mdl-23359691
4.
IsoTag™AAV: an innovative, scalable & non-chromatographic method for streamlined AAV manufacturing.
Cell Gene Ther Insights
; 8(10): 1287-1300, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-37712070
5.
Ultrasensitive point-of-care immunoassay for secreted glycoprotein detects Ebola infection earlier than PCR.
Sci Transl Med
; 13(588)2021 04 07.
Article
in English
| MEDLINE | ID: mdl-33827978
6.
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature-triggered hierarchical self-assembly.
Nat Chem
; 10(5): 496-505, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29556049
7.
One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer.
Nat Biomed Eng
; 12017.
Article
in English
| MEDLINE | ID: mdl-29062587
8.
Controlled release of biologics for the treatment of type 2 diabetes.
J Control Release
; 240: 151-164, 2016 10 28.
Article
in English
| MEDLINE | ID: mdl-26655062
9.
A brush-polymer conjugate of exendin-4 reduces blood glucose for up to five days and eliminates poly(ethylene glycol) antigenicity.
Nat Biomed Eng
; 12016.
Article
in English
| MEDLINE | ID: mdl-28989813
Results
1 -
9
de 9
1
Next >
>>